![Edward Kaye](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 4 M $ in data 31/05/2026
Dr. Edward M.
Kaye, MD, is a Chief Executive Officer & Director at Aurora Therapeutics, Inc., an Independent Director at Cytokinetics, Inc. and an Advisory Board Member at CureDuchenne Ventures LLC.
He is on the Board of Directors at Aurora Therapeutics, Inc., Stoke Therapeutics, Inc., Cytokinetics, Inc., Massachusetts Biotechnology Council and Convergence Bio, Inc. Dr. Kaye was previously employed as an Independent Director by Avidity Biosciences, Inc., an Independent Director by NeuroVia, Inc., a Group VP-Medical Affairs & Clinical Development by Genzyme Corp., a Chief-Biochemical Genetics by The Children's Hospital of Philadelphia, a Chief-Neurology by St. Christopher's Hospital for Children LLC, and an Associate Professor by Perelman School of Medicine.
He also served on the board at Sarepta Therapeutics, Inc. He received his undergraduate degree from Loyola University New Orleans and a doctorate degree from Stritch School of Medicine.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 03/06/2026 | 110.874 ( 0,19% ) | 3 M $ | 31/05/2026 | |
| 01/06/2026 | 10.283 ( 0,01% ) | 789 323 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Direttore/Membro del Consiglio | 20/05/2016 |
| STOKE THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/10/2017 |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Direttore/Membro del Consiglio | 01/03/2016 |
CureDuchenne Ventures LLC
 CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures seeks investment opportunities located in the United States. The firm targets companies operating in the fields of health technology companies. It provides financing for early-stage capital requirements. | Consulente / Consigliere | - |
| Società | Posizione | Fine |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 27/02/2026 |
| SAREPTA THERAPEUTICS, INC. | Amministratore Delegato | 01/07/2017 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Direttore Tecnico/Scientifico/R&S | 01/06/2011 |
The Children's Hospital of Philadelphia
 The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services Operates hospitals | Corporate Officer/Principal | 01/01/2001 |
St. Christopher's Hospital for Children LLC
 St. Christopher's Hospital for Children LLC Medical/Nursing ServicesHealth Services Provides health care services | Corporate Officer/Principal | 01/01/1998 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Avidity Biosciences, Inc.
 Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
Loyola University New Orleans
 Loyola University New Orleans Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
St. Christopher's Hospital for Children LLC
St. Christopher's Hospital for Children LLC Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Perelman School of Medicine
 Perelman School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stritch School of Medicine
 Stritch School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Children's Hospital of Philadelphia
The Children's Hospital of Philadelphia Hospital/Nursing ManagementHealth Services Operates hospitals | Health Services |
NeuroVia, Inc.
 NeuroVia, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule therapeutics for the treatment of neurologic disorders | Health Technology |
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures seeks investment opportunities located in the United States. The firm targets companies operating in the fields of health technology companies. It provides financing for early-stage capital requirements. | Finance |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
